Corporate Profile

Nanosphere, Inc. is dedicated to enhancing medicine by providing targeted molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment and improved healthcare economics.

Our platform, the Verigene® System, enables clinicians to rapidly identify and treat many of the bacteria and viruses responsible for some of the most complex, costly and deadly infectious diseases. The Verigene System uses Nanosphere’s proprietary gold nanoparticle chemistry to offer simple-to-use, highly accurate multiplex molecular diagno... More >>

Stock Quote
NSPH (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$1.82
Change (%) Stock is Down 0.03 (1.62%)
Volume418,482
Data as of 04/24/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock chart for: 03NA000000NSPH
PresentationsMore >>
DateTitle
04/10/14
Download Documentation Needham Healthcare Conference Presentation
Recent NewsMore >>
04/17/14 - 8:00 a.m.
Nanosphere to Release First Quarter Results and Host Investor Conference Call on Wednesday, May 7, 2014
04/04/14 - 6:30 p.m.
Nanosphere Clarifies Recent Transactions in Company's Common Stock
04/03/14 - 5:00 p.m.
Nanosphere to Present at the 13th Annual Needham Healthcare Conference
Upcoming EventsMore >>
DateTitle
05/07/14 10:00 a.m. ET
Q1 2014 NANOSPHERE INC Earnings Conference Call
05/19/14
through
05/21/14
NANOSPHERE INC at UBS Global Healthcare Conference
LocationNew York, NY US

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet